Ohno et al. have shown that ANXA2 is upregulated in primary clear cell renal carcinoma cells (ccRCCs) compared with normal renal cortex; 47.4% of primary ccRCCs tissue and 87.5% of metastatic tumors are positive for ANXA2. This evidence concerns the gene ANXA2 and clear cell renal carcinoma.